Description
PE-22-28 10mg
PE-22-28 is an experimental peptide derived from the spadin research pathway and has been investigated in preclinical models involving TREK-1 potassium-channel signalling and neurobiological processes.
Research interest includes TREK-1 modulation, neuronal signalling, neurogenesis and behavioural-model research. The evidence base is preclinical and PE-22-28 remains an experimental laboratory research peptide.
Research Areas of Interest
- TREK-1 potassium-channel research
- Neuronal signalling
- Neurogenesis
- Synaptic and neurobiological pathways
- Preclinical behavioural models
Product Specification
Product: PE-22-28
Strength: 10mg
Format: Lyophilised research peptide
Contents: 1 vial
Purity: Refer to batch-specific analytical documentation
Availability: See the current stock status and options above
Ordering & Documentation
Check the stock status and available options above before ordering. For documentation covering the product format and batch, visit our document library or ask the Alpha team.
For laboratory research use only. Not for human consumption.
Reviews
There are no reviews yet.